Small Business Resources, Business Advice and Forms from AllBusiness.com
 

Ohio State University Medical Center to Train Doctors in New Surgical Treatment for Congestive...

Business Editors, Health & Medical Writers

COLUMBUS, Ohio--(BUSINESS WIRE)--Sept. 26, 2002

The Ohio State University Medical Center is launching a new program to train doctors in an emerging surgical procedure which may extend and improve the lives of certain patients with

one of the most serious health problems in the U.S. - congestive heart failure (CHF).

OSUMC's Cardiothoracic Surgery and Cardiology Divisions are sponsoring the program in Surgical Ventricular Restoration (SVR). The program is designed for cardiac surgeons, cardiologists, internists and other healthcare providers involved in the diagnosis and care of patients with severe CHF. The initial one-day program will be conducted in Columbus, Ohio on Thursday, November 7, and is supported by an educational grant from Somanetics Corporation (Nasdaq:SMTS).

"Given the outlook for many CHF patients - 50 percent die within five years of diagnosis - the key to combating the disease lies in cost-efficient therapies that go beyond treating its symptoms," said Robert Michler, M.D., chief of cardiothoracic surgery. "SVR is an exciting alternative because, by repairing and improving the function of the ventricle, the procedure treats the underlying cause of CHF. As a result, patients are able to better manage their condition, which in turn reduces their chances of repeated hospitalizations."

CHF occurs when the heart is unable to pump enough blood to meet the body's demand for oxygen and other nutrients. For many patients, the underlying cause of CHF is an enlarged, poorly-functioning left ventricle - the result of the body's effort to compensate for heart muscle damage caused by a heart attack. To adjust to the damage, the heart enlarges and works inefficiently.

About five million people in the U.S. have CHF, and more than a half million new cases are diagnosed annually. CHF and related causes result in approximately 250,000 deaths in the U.S. each year. For people over 65, the disease is the most common cause of hospital admissions.

During the SVR operation, performed on certain CHF patients whose hearts have been damaged by a heart attack, the surgeon restores the damaged ventricle to more normal size and function.

The surgeon opens the ventricle and excludes the scarred, non-contracting segments of the heart most commonly by inserting a patch, or by direct closure. The restored heart is immediately able to function more efficiently due to the improved cardiac structure.

In addition, make sure to read these articles:

  • A surgeon shortage?
  • The latest issue of KPMG Health Care Insider leads with a story suggesting that there is a shortage of surgeons in many areas, and offers ......
  • Is it too expensive to be a primary care doctor?
  • High debt, flat and declining reimbursement and rising costs make the lot of primary care physicians rather unattractive these days.The CEO of a large practice ......
  • Leading physician groups call for health reform
  • Ten of the nation's leading physician associations today called on reform of the US health care system based upon 11 key principles. By coming together ......
  • LVADs help some regain cardiac function...
  • Left ventricular assist devices (LVADs) originally were designed as bridges to cardiac transplantation, allowing patients with congestive heart failure to survive until a donor heart ......
  • Help for county budget Ills seen in outpatient...
  • Every day, cardiologists at Olive View-UCLA Medical Center face a dilemma that exemplifies the county's troubles in trying to close a widening gap in its ......
  • Telemedicine units a big help for patients,...
  • TUPELO - Thanks to the work of cardiac clinician Melody Poole and Dr. Ken Harvey, with North Mississippi Medical Center's (NMMC) Home Health Agency in ......
  • Managing diseases by managing IT.
  • Disease management programs are moving out of pilot incarnations and into a more powerful second phase of development. Those involved in the early efforts say ......
  • HP Marks Entry into Disease-Management Market,...
  • PALO ALTO, Calif.--(BW HealthWire)--June 3, 1999-- Solution for CHF Patients in Final Stage of Development and Testing Marking its entry into the disease-management market, Hewlett-Packard ......
  • Minnesota Heart Failure Consortium Launches...
  • Business Editors/Health/Medical Writers BROOKLYN PARK, Minn.--(BUSINESS WIRE)--Feb. 4, 2004 CHF Solutions, a private medical device manufacturer, announced today that the Minnesota Heart Failure Consortium (MHFC), ......
  • Tishcon Corp. Receives Orphan Drug Designations...
  • Business Editors/Health/Medical Writers WESTBURY, N.Y.--(BUSINESS WIRE)--April 22, 2004 TISHCON CORP. announced that the U.S. FDA has granted the firm Orphan Drug Designations for UBIQUINOL (Coenzyme ......
  • RCT Completes Early Preclinical Work on...
  • Business Editors/Health/Medical Writers TUCSON, Ariz.--(BUSINESS WIRE)--April 1, 2003 Preclinical studies of chimeric natriuretic peptides to rapidly treat acute congestive heart failure (CHF) show lead candidates ......
  • Data from Two Published Studies Show Short- and...
  • BROOKLYN PARK, Minn. -- Benefits Include Greater Fluid Removal, Weight Loss and Symptom Relief, as Well As Less Hospitalization CHF Solutions, a private medical ......
  • Interneuron acquires additional stake in...
  • LEXINGTON, Mass.--(BUSINESS WIRE)--Jan. 18, 1996--Interneuron Pharmaceuticals Inc. (NASDAQ: IPIC) today announced that it has acquired all of the remaining shares of CPEC Inc. not held ......
  • Patent for Treatment of Congestive Heart...
  • BOXFORD, Mass.--(BW HealthWire)--Aug. 31, 1998--Milkhaus Laboratory Inc., a clinical stage biopharmaceutical company, announced today that it had been granted a patent for its product for ......
  • CardioDynamics Announces Meeting of Prominent...
  • SAN DIEGO--(BW HealthWire)--Aug. 17, 1999-- CardioDynamics International Corp. (Nasdaq:CDIC), manufacturer of BioZ(R) noninvasive digital hemodynamic monitoring systems, today announced a meeting of prominent heart failure ......
presented by